Weight-to-waist circumference index enhances interpretable machine learning models for screening depressive symptoms in middle-aged and elderly adults comorbid with hypertension and diabetes.
Aug 2026· Nutrición Hospitalaria· 0 citations· 36 references
Medicine
TL;DR
Novel composite indices (especially WWI, ABSI, TyG) have substantial clinical value for depression symptom screening in this population of patients with comorbid hypertension and diabetes and the interpretable model provides a convenient, effective screening tool for clinical practice.
Abstract
Objective
patients with comorbid hypertension and diabetes are at elevated risk of depressive symptoms, but simple metabolic predictors are insufficient. This study aimed to develop an interpretable machine learning model incorporating clinical data and novel composite indices for early screening of depressive symptoms.
Methods
a total of 546 participants ≥45 years with the comorbidities were enrolled from CHARLS (2011-2020). Eight composite indices (TyG, WHtR, WHT.5R, WWI, ABSI, CTI, hsCRP/HDL, log_tg) were included. Restricted cubic splines explored dose-response relationships. Ten machine learning models were compared via AUC, calibration curves, and DCA; SHAP interpreted the optimal model.
Results
the Gradient Boosting model performed best (validation AUC = 0.899, good calibration). SHAP identified frailty score and WWI as top predictors, with ABSI and TyG also contributing significantly. Subgroup analyses confirmed robust generalizability across gender and age in screening for depressive symptoms.
Conclusion
novel composite indices (especially WWI, ABSI, TyG) have substantial clinical value for depression symptom screening in this population. The interpretable model provides a convenient, effective screening tool for clinical practice.
CKMAI is a valid, CKM‑specific index that outperforms universal biological age measures in predicting mortality and high‑risk CKM status and consistently outperformed PhenoAge, KDM, and the cardiometabolic index across all outcomes.
Zheng-Yang Zhu, Ke-Jun Ren, Dong Wang et al.· PLoS Medicine· 0 citations
Objective To explore the potential incremental value of metabolic-inflammatory and insulin-resistance indices for diagnosing mild cognitive impairment (MCI) in type 2 diabetes (T2DM), and to furnish new candidate tools and insights for the risk stratification and early recognition of diabetes-related cognitive dysfunct...
Yan-Ning Cao, Cong-Han Lei, Jian-Hui Liu et al.· Diabetes, Metabolic Syndrome...· 0 citations
Background/Objectives: Machine learning is increasingly applied to identify hypertension from broad predictor panels, but whether it outperforms a few routine measurements is unclear. We compared machine learning pipelines against three readily obtained variables in a national Chilean survey. Methods: We analysed 5516...
Rodrigo Yáñez-Sepúlveda, Boryi A. Becerra-Patiño, Felipe Montalva-Valenzuela et al.· Diagnostics· 0 citations
Background: The incremental contribution of psychological measures to population-based diabetes screening remains uncertain. Objectives: To classify current glycemic status as diabetes versus normal/prediabetes and to evaluate whether psychological measures provide incremental screening information beyond demographic a...
M. Mahmoodabadi, Afsaneh Taheri, M. Sanjari· Iranian Journal of Psychiatr...· 0 citations
Background/Objectives: Type 2 diabetes mellitus (T2DM) is characterized by overlapping cardiovascular, renal, metabolic, and hepatic-risk abnormalities. We characterized this integrated phenotype, examined SCORE2-Diabetes gradients, and assessed whether routinely available variables could classify established atheroscl...
Bianca-Lăcrimioara Petca, Paula-Alexandra Popovici, Andreea Igna et al.· Journal of Clinical Medicine· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.